癌症中的非典型R循环:解码分子混乱以获得治疗效益
Yuan Sun1,2, Sheng Wang1,2, Nan Ge1,2
1Department of Gastroenterology, Shengjing Hospital of China Medical University, Shenyang, 110004, Liaoning, People's Republic of China.
Journal of translational medicine
|August 14, 2025
概括
非经典的DNA-RNA混合结构称为R-循环与疾病有关. 了解瘤细胞中的R循环调节可能会导致新的癌症疗法.
科学领域:
- 基因组学就是基因组学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- R-循环是DNA-RNA混合结构,对细胞过程至关重要,如类交换机重组.
- R环的失调与各种疾病有关.
- 通过不同的机制形成的非经典的R环,发挥着各种各样的细胞作用.
研究的目的:
- 审查目前对瘤细胞中非经典R环的理解.
- 探索调节癌症R环的机制.
- 为了确定R环相关瘤的潜在治疗点.
主要方法:
- 对非经典R环研究的文献综述.
- 在癌症中分析R循环的形成,调节和功能.
- 确定针对R循环失调的治疗策略.
主要成果:
- 与正常细胞相比,非经典的R环在瘤细胞中表现出改变的水平和调节机制.
- 这些R环影响瘤细胞生物学的各个方面.
- 特定的R-循环调节机制提供了独特的治疗机会.
结论:
- 非经典的R环是瘤发生的重要参与者.
- 准R循环平衡为精确瘤学提供了一个有前途的途径.
- 进一步阐明R环病原机制可以推动创新的癌症治疗.
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
lncRNA - Long Non-coding RNAs
8.9K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.9K
Rous Sarcoma Virus (RSV) and Cancer
5.4K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.4K
Non-LTR Retrotransposons
11.9K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.9K
Cancer-Critical Genes II: Tumor Suppressor Genes
8.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.0K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K


